Literature DB >> 9181479

Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats.

Y M Pinto1, H Buikema, W H van Gilst, E Scholtens, P P van Geel, P A de Graeff, J Wagner, M Paul.   

Abstract

To compare hypertensive end-organ damage in two genetic forms of hypertension we assessed cardiovascular function in two rat strains of genetic hypertension: transgenic rats overexpressing the mouse Ren-2 gene [(TGR(mREN2)27]) and blood pressure matched spontaneously hypertensive rats (SHR). Despite similarly elevated blood pressure, systolic dp/dt (mmHg/s) was more impaired in transgenic rats (3099 +/- 446) than in SHR (3571 +/- 272) and normals (4342 +/- 119; P < 0.05). Left ventricular weight (mg/g body weight) increased more in the transgenic rats (40 +/- 3) than in SHR (31 +/- 2) and normals (26 +/- 2). Endothelium-dependent relaxation was significantly decreased only in the transgenic rats. This study shows significantly more cardiac and endothelial dysfunction in transgenic, hypertensive TGR (mREN2)27 than in age and blood pressure matched SHR. This supports the hypothesis that chronic activation of the renin-angiotensin system significantly contributes to hypertensive end-organ damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181479     DOI: 10.1007/s001090050123

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  8 in total

1.  Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Megan S Johnson; Javad Habibi; Lakshmi Pulakat; Rukhsana Gul; Melvin R Hayden; Roger D Tilmon; Kevin C Dellsperger; Nathaniel Winer; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

2.  Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Exercise training prevents development of cardiac contractile dysfunction in hypertensive TG (mREN-2)27 rats.

Authors:  R Tyler Morris; Deborah M Fine; Simon J Lees; Frank W Booth; C Daniel Link; Carlos M Ferrario; Craig S Stump; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2007 Nov-Dec

4.  Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure.

Authors:  A E Loot; A J M Roks; D Westermann; H-D Orzechowski; C Tschöpe; J C Wilschut; R A Tio; W H van Gilst; R H Henning
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

5.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

6.  Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

Authors:  Hans Imboden; Jaspal Patil; Juerg Nussberger; Françoise Nicoud; Benno Hess; Nermin Ahmed; Thomas Schaffner; Maren Wellner; Dominik Müller; Tadashi Inagami; Takaaki Senbonmatsu; Jaroslav Pavel; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-02-12

Review 7.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 8.  Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis.

Authors:  Xin-Fang Leong; Chun-Yi Ng; Kamsiah Jaarin
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.